[Survivin supressant: a promising target for cancer therapy and pharmacological profiles of YM155].
Kita A, Nakahara T, Takeuchi M, Kinoyama I, Yamanaka K, Minematsu T, Mitsuoka K, Fushiki H, Miyoshi S, Sasamata M, Miyata K.
Kita A, et al. Among authors: fushiki h.
Nihon Yakurigaku Zasshi. 2010 Oct;136(4):198-203. doi: 10.1254/fpj.136.198.
Nihon Yakurigaku Zasshi. 2010.
PMID: 20948154
Review.
Japanese.
No abstract available.